660P - Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies
Autor: | Klempner, S.J., Bendell, J., Meucci Villaflor, V., Tenner, L., Stein, S., Sirard, C.A., Newman, W., Kagey, M., Schlienger, K., Strickler, J. |
---|---|
Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
Databáze: | ScienceDirect |
Externí odkaz: |